Building Trust in Telemedicine
Dr Jawahar Shah throws light on the workthat Mind Technologies, a company that hefounded, has done for connecting rural and […]
Say something
Dr Jawahar Shah throws light on the workthat Mind Technologies, a company that hefounded, has done for connecting rural and […]
Evidence-based decision support programs may be able to reduce the number of unnecessary CT pulmonary angiographic exams used to uate […]
Gynesonics has begun a multicentre clinical trial to assess the effectiveness of the VizAblate system for the treatment of uterine fibroids associated with heavy menstrual bleeding.
A mobile X-ray service has proved to be a cost-effective way of treating homeless people and drug addicts with tuberculosis (TB), according to a study published in the British Medical Journal.
Diabetics treated by doctors who use electronic medical records have better quality of care regardless of what type of insurance they have than those whose practitioners use paper records, a study showed.
Electronic health records can help doctors give their patients the best care, at least when it comes to diabetes, U.S. researchers reported.
Biotronik has reported the results of its Home Monitoring in Cardiac Resynchronisation Therapy clinical study.
The US National Institutes of Health (NIH) has awarded a five-year, $2.2m grant to researchers to study biomarkers in the blood of traumatic brain injury (TBI) patients.
The use of remote robotic telemedicine technology in neonatal intensive care units is a safe and feasible way to provide care in hospitals with a limited work force, according to a study published in the Journal of Perinatology, InformationWeek reports.
Staying in shape can be just as beneficial for the brain as the body, a large-scale study released suggests.
A study among couples showed early use of drugs slashed the risk of HIV infection through sex by 96 per cent.
A study in Health Affairs states that implementing EHRs in primary care practices with five physicians would cost each doctor an average of $46,659 for the first year.
The US Food and Drug Administration has given a tentative approval for Aurobindo Pharma to market the generic Famciclovir tablets which are used to treat herpes virus infections.